Literature DB >> 30900725

Mechanistic target of rapamycin signaling in mouse models of accelerated aging.

Jin Young Lee1, Brian K Kennedy1,2,3,4, Chen-Yu Liao1.   

Abstract

The mechanistic target of rapamycin (mTOR) is an essential nutrient-sensing kinase that integrates and regulates a number of fundamental cellular processes required for cell growth, cell motility, translation, metabolism, and autophagy. mTOR signaling has been implicated in the progression of many human diseases, and its dysregulation has been reported in several pathological processes, especially in age-related human diseases and mouse models of accelerated aging. In addition, many studies have demonstrated that the regulation of mTOR activity has a beneficial effect on longevity in several mouse models of aging. However, not all mouse models of accelerated aging show positive effects on aging-associated phenotypes in response to targeting mTOR signaling. Here, we review the effects of interventions that modulate mTOR signaling on aging-related phenotypes in different mouse models of accelerated aging and discuss their implications with respect to aging and aging-related disorders.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Age-associated disease; Dietary restriction; Mice; Rapamycin; mTORC1

Mesh:

Substances:

Year:  2020        PMID: 30900725      PMCID: PMC6909891          DOI: 10.1093/gerona/glz059

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  95 in total

1.  Premature aging in mice activates a systemic metabolic response involving autophagy induction.

Authors:  Guillermo Mariño; Alejandro P Ugalde; Natalia Salvador-Montoliu; Ignacio Varela; Pedro M Quirós; Juan Cadiñanos; Ingrid van der Pluijm; José M P Freije; Carlos López-Otín
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

2.  Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.

Authors:  Veerendra Kumar Madala Halagappa; Zhihong Guo; Michelle Pearson; Yasuji Matsuoka; Roy G Cutler; Frank M Laferla; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2007-01-13       Impact factor: 5.996

3.  The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

Authors:  Maria Sörhede Winzell; Bo Ahrén
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

4.  Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.

Authors:  Roman V Kondratov; Anna A Kondratova; Victoria Y Gorbacheva; Olena V Vykhovanets; Marina P Antoch
Journal:  Genes Dev       Date:  2006-07-15       Impact factor: 11.361

5.  Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.

Authors:  Emanuela Santini; Myriam Heiman; Paul Greengard; Emmanuel Valjent; Gilberto Fisone
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

6.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

7.  Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.

Authors:  Fresnida J Ramos; Steven C Chen; Michael G Garelick; Dao-Fu Dai; Chen-Yu Liao; Katherine H Schreiber; Vivian L MacKay; Elroy H An; Randy Strong; Warren C Ladiges; Peter S Rabinovitch; Matt Kaeberlein; Brian K Kennedy
Journal:  Sci Transl Med       Date:  2012-07-25       Impact factor: 17.956

8.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

9.  p53 and rapamycin are additive.

Authors:  Barbara Christy; Marco Demaria; Judith Campisi; Jing Huang; Diane Jones; Sherry G Dodds; Charnae Williams; Gene Hubbard; Carolina B Livi; Xiaoli Gao; Susan Weintraub; Tyler Curiel; Z Dave Sharp; Paul Hasty
Journal:  Oncotarget       Date:  2015-06-30

10.  Accelerated epigenetic aging in Down syndrome.

Authors:  Steve Horvath; Paolo Garagnani; Maria Giulia Bacalini; Chiara Pirazzini; Stefano Salvioli; Davide Gentilini; Anna Maria Di Blasio; Cristina Giuliani; Spencer Tung; Harry V Vinters; Claudio Franceschi
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

View more
  7 in total

Review 1.  The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

Authors:  Hanne Leysen; Deborah Walter; Lore Clauwaert; Lieselot Hellemans; Jaana van Gastel; Lakshmi Vasudevan; Bronwen Martin; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

2.  TORwards a Victory Over Aging.

Authors:  Dudley W Lamming; Adam B Salmon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.591

3.  Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.

Authors:  Célia A Aveleira; Marisa Ferreira-Marques; Luísa Cortes; Jorge Valero; Dina Pereira; Luís Pereira de Almeida; Cláudia Cavadas
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

Review 4.  Still Living Better through Chemistry: An Update on Caloric Restriction and Caloric Restriction Mimetics as Tools to Promote Health and Lifespan.

Authors:  Carla Almendáriz-Palacios; Darrell D Mousseau; Christopher H Eskiw; Zoe E Gillespie
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 5.  Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells.

Authors:  Huarui Cai; Zhongze Wang; Wenhan Tang; Xiaoxue Ke; Erhu Zhao
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

Review 6.  Molecular and Mechanobiological Pathways Related to the Physiopathology of FPLD2.

Authors:  Alice-Anaïs Varlet; Emmanuèle Helfer; Catherine Badens
Journal:  Cells       Date:  2020-08-23       Impact factor: 6.600

Review 7.  MUT-7 Provides Molecular Insight into the Werner Syndrome Exonuclease.

Authors:  Tsung-Yuan Hsu; Ling-Nung Hsu; Shih-Yu Chen; Bi-Tzen Juang
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.